Latest IPLEDGE Stories

PRINCETON, N.J., Nov. 26, 2012 /PRNewswire/ -- Ranbaxy Laboratories, Inc. (RLI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), today announced the sales and promotion launch of Absorica (Isotretinoin) Capsules, a product that is licensed from Cipher Pharmaceuticals Inc. of Mississauga, Ontario. Absorica is indicated for the treatment of severe recalcitrant nodular acne in patients 12 years of age and older. Due to its high lipophilicity, oral absorption of...

The online Canadian pharmacy Big Mountain Drugs is offering teens struggling with both acne and the high price of acne medications a bargain on popular prescription acne treatments. Vancouver, BC (PRWEB) August 08, 2011 Most (approximately 85%) of teens develop some sort of acne. The teen age years are a time when our personalities and self concept are developing, and acceptance from our peers is vitally important to us. Taunts like "pizza face" are hurtful at any age, but can be...

SCHAUMBURG, Ill., Nov. 22, 2010 /PRNewswire-USNewswire/ -- The American Academy of Dermatology Association (AADA) recently updated its position statement on the use of isotretinoin. The position continues to state that patient safety is dermatologists' primary concern and that the AADA is committed to the safe and responsible use of isotretinoin, which is the most effective treatment for severe acne. "Isotretinoin continues to be considered a critically important drug for treating patients...

Association of suicide attempts with acne and treatment with isotretinoin: Retrospective Swedish cohort studyIndividuals who suffer from severe acne are at an increased risk of attempting suicide, according to a paper published on bmj.com today.The study also finds that an additional risk may be present during and up to one year after treatment with isotretinoin, a commonly prescribed drug for severe acne. However, the authors stress that this additional risk is most likely due to the acne...

The U.S. Food and Drug Administration says it won't appeal a federal court order directing it to permit the Plan B drug to be available without prescription. The March 23 court order directed the FDA to act within 30 days, to permit Plan B (levonorgestrel) to be made available to women 17 and older without a prescription. Plan B is an emergency contraception drug designed to prevent pregnancy when taken up to 72 hours after unprotected sexual intercourse. In accordance with the court's...

InfoMedics, Inc., the patient feedback company, today announced the results of a survey examining the behaviors of patients on prescription medications. The findings show that a significant portion of medication users tend to ignore or stray from their doctor's orders, and that there are opportunities for improved patient-physician communication. Thirty-four percent of respondents said they do not always fill a new prescription from their doctors; another 5 percent said they never fill those...

WASHINGTON (Reuters) - A well-known acne drug may increase cholesterol and other fat levels more than previously thought, U.S. researchers said on Monday. The drug isotretinoin, sold as Roche AG's Accutane as well as a generic, raised levels of triglyceride fats in about 44 percent of patients with previously normal levels, the University of California San Francisco analysis found. Total cholesterol levels were higher for 31 percent of patients. Previously, clinical trials of Accutane...

WASHINGTON (Reuters) - A well-known acne drug may increase cholesterol and other fat levels more than previously thought, U.S. researchers said on Monday.The drug isotretinoin, sold as Roche AG's Accutane as well as a generic, raised levels of triglyceride fats in about 44 percent of patients with previously normal levels, the University of California San Francisco analysis found. Total cholesterol levels were higher for 31 percent of patients.Previously, clinical trials of Accutane showed...

By Susan HeaveyWASHINGTON (Reuters) - The Food and Drug Administration on Thursday said it will implement new restrictions on a widely used acne drug next Wednesday in an effort to curb birth defects, rejecting calls from some doctors to delay the program.Some doctors have said the revised limits on prescribing Accutane, sold by Switzerland's Roche AG but also available in generic form, are too cumbersome and take up too much time. Dermatologists had asked the agency to delay the program for...

By Lisa Richwine GAITHERSBURG, Maryland (Reuters) - A plan to prevent birth defects from a widely used acne drug is placing heavy burdens on doctors, patients and pharmacists and should be halted until flaws can be fixed, doctors said on Friday. The restrictions on Roche AG's Accutane or generic versions are so cumbersome and time-consuming they may send patients to the Internet, where medicines may be counterfeit and there are no safeguards to prevent pregnancy, critics said. Accutane...